{"id":"https://openalex.org/W4287218671","doi":"https://doi.org/10.1080/14756366.2022.2103552","title":"Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation","display_name":"Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation","publication_year":2022,"publication_date":"2022-07-25","ids":{"openalex":"https://openalex.org/W4287218671","doi":"https://doi.org/10.1080/14756366.2022.2103552","pmid":"https://pubmed.ncbi.nlm.nih.gov/35875937","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9327782"},"language":"en","primary_location":{"id":"doi:10.1080/14756366.2022.2103552","doi":"https://doi.org/10.1080/14756366.2022.2103552","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14756366.2022.2103552","pdf_url":null,"source":{"id":"https://openalex.org/S192603849","display_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","issn_l":"1475-6366","issn":["1475-6366","1475-6374"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1080/14756366.2022.2103552","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007786874","display_name":"Mohammed S. Taghour","orcid":"https://orcid.org/0000-0003-0630-709X","observed_orcids":["https://orcid.org/0000-0003-0630-709X"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I4210125886","display_name":"Al-Azhar University","ror":"https://ror.org/03ewepe58","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210125886"]}],"countries":["EG","ID"],"is_corresponding":false,"raw_author_name":"Mohammed S. Taghour","raw_affiliation_strings":["Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University","Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University","institution_ids":["https://openalex.org/I184834183","https://openalex.org/I4210125886"]},{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111042471","display_name":"Hazem A. Mahdy","orcid":"https://orcid.org/0000-0002-6620-241X","observed_orcids":["https://orcid.org/0000-0002-6620-241X"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I4210125886","display_name":"Al-Azhar University","ror":"https://ror.org/03ewepe58","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210125886"]}],"countries":["EG","ID"],"is_corresponding":false,"raw_author_name":"Hazem A. Mahdy","raw_affiliation_strings":["Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University","Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt"],"raw_orcid":"https://orcid.org/0000-0002-6620-241X","affiliations":[{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University","institution_ids":["https://openalex.org/I184834183","https://openalex.org/I4210125886"]},{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087138772","display_name":"Maher Hassan Gomaa","orcid":"https://orcid.org/0000-0003-4623-6978","observed_orcids":["https://orcid.org/0000-0003-4623-6978"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I4210125886","display_name":"Al-Azhar University","ror":"https://ror.org/03ewepe58","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210125886"]},{"id":"https://openalex.org/I4210161182","display_name":"Al Azhar University","ror":"https://ror.org/02pwa4b62","country_code":"QA","type":"education","lineage":["https://openalex.org/I4210161182"]}],"countries":["EG","ID","QA"],"is_corresponding":false,"raw_author_name":"Maher H. Gomaa","raw_affiliation_strings":["Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University","Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University","institution_ids":["https://openalex.org/I184834183","https://openalex.org/I4210125886","https://openalex.org/I4210161182"]},{"raw_affiliation_string":"Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081553552","display_name":"Ahmed Aglan","orcid":"https://orcid.org/0000-0001-7058-5997","observed_orcids":["https://orcid.org/0000-0001-7058-5997"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I4210125886","display_name":"Al-Azhar University","ror":"https://ror.org/03ewepe58","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210125886"]},{"id":"https://openalex.org/I4210161182","display_name":"Al Azhar University","ror":"https://ror.org/02pwa4b62","country_code":"QA","type":"education","lineage":["https://openalex.org/I4210161182"]}],"countries":["EG","ID","QA"],"is_corresponding":false,"raw_author_name":"Ahmed Aglan","raw_affiliation_strings":["Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University","Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University","institution_ids":["https://openalex.org/I184834183","https://openalex.org/I4210125886","https://openalex.org/I4210161182"]},{"raw_affiliation_string":"Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048319591","display_name":"Mahmoud Gomaa Eldeib","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I4210125886","display_name":"Al-Azhar University","ror":"https://ror.org/03ewepe58","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210125886"]},{"id":"https://openalex.org/I4210161182","display_name":"Al Azhar University","ror":"https://ror.org/02pwa4b62","country_code":"QA","type":"education","lineage":["https://openalex.org/I4210161182"]}],"countries":["EG","ID","QA"],"is_corresponding":false,"raw_author_name":"Mahmoud Gomaa Eldeib","raw_affiliation_strings":["Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University","Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University","institution_ids":["https://openalex.org/I184834183","https://openalex.org/I4210125886","https://openalex.org/I4210161182"]},{"raw_affiliation_string":"Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026432056","display_name":"Alaa Elwan","orcid":"https://orcid.org/0000-0003-4270-616X","observed_orcids":["https://orcid.org/0000-0003-4270-616X"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I4210125886","display_name":"Al-Azhar University","ror":"https://ror.org/03ewepe58","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210125886"]}],"countries":["EG","ID"],"is_corresponding":false,"raw_author_name":"Alaa Elwan","raw_affiliation_strings":["Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University","Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University","institution_ids":["https://openalex.org/I184834183","https://openalex.org/I4210125886"]},{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048133390","display_name":"Mohammed A. Dahab","orcid":"https://orcid.org/0000-0002-2016-0728","observed_orcids":["https://orcid.org/0000-0002-2016-0728"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I4210125886","display_name":"Al-Azhar University","ror":"https://ror.org/03ewepe58","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210125886"]}],"countries":["EG","ID"],"is_corresponding":false,"raw_author_name":"Mohammed A. Dahab","raw_affiliation_strings":["Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University","Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University","institution_ids":["https://openalex.org/I184834183","https://openalex.org/I4210125886"]},{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074335644","display_name":"Eslam B. Elkaeed","orcid":"https://orcid.org/0000-0002-2546-8035","observed_orcids":["https://orcid.org/0000-0002-2546-8035"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I4210125886","display_name":"Al-Azhar University","ror":"https://ror.org/03ewepe58","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210125886"]},{"id":"https://openalex.org/I4210161182","display_name":"Al Azhar University","ror":"https://ror.org/02pwa4b62","country_code":"QA","type":"education","lineage":["https://openalex.org/I4210161182"]}],"countries":["EG","ID","QA"],"is_corresponding":false,"raw_author_name":"Eslam B. Elkaeed","raw_affiliation_strings":["Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University","Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University","institution_ids":["https://openalex.org/I184834183","https://openalex.org/I4210125886","https://openalex.org/I4210161182"]},{"raw_affiliation_string":"Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028997078","display_name":"Aisha A. Alsfouk","orcid":"https://orcid.org/0000-0003-4497-5013","observed_orcids":["https://orcid.org/0000-0003-4497-5013"]},"institutions":[{"id":"https://openalex.org/I106778892","display_name":"Princess Nourah bint Abdulrahman University","ror":"https://ror.org/05b0cyh02","country_code":"SA","type":"education","lineage":["https://openalex.org/I106778892"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Aisha A. Alsfouk","raw_affiliation_strings":["Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University","Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0003-4497-5013","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University","institution_ids":["https://openalex.org/I106778892"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia","institution_ids":["https://openalex.org/I106778892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029891269","display_name":"Mohamed M. Khalifa","orcid":"https://orcid.org/0000-0002-8146-993X","observed_orcids":["https://orcid.org/0000-0002-8146-993X"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I4210125886","display_name":"Al-Azhar University","ror":"https://ror.org/03ewepe58","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210125886"]}],"countries":["EG","ID"],"is_corresponding":false,"raw_author_name":"Mohamed M. Khalifa","raw_affiliation_strings":["Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University","Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt"],"raw_orcid":"https://orcid.org/0000-0002-8146-993X","affiliations":[{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University","institution_ids":["https://openalex.org/I184834183","https://openalex.org/I4210125886"]},{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020589815","display_name":"Ibrahim H. Eissa","orcid":"https://orcid.org/0000-0002-6955-2263","observed_orcids":["https://orcid.org/0000-0002-6955-2263"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I4210125886","display_name":"Al-Azhar University","ror":"https://ror.org/03ewepe58","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210125886"]}],"countries":["EG","ID"],"is_corresponding":true,"raw_author_name":"Ibrahim H. Eissa","raw_affiliation_strings":["Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University","Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt"],"raw_orcid":"https://orcid.org/0000-0002-6955-2263","affiliations":[{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University","institution_ids":["https://openalex.org/I184834183","https://openalex.org/I4210125886"]},{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048991764","display_name":"Hazem Elkady","orcid":"https://orcid.org/0000-0003-0893-6703","observed_orcids":["https://orcid.org/0000-0003-0893-6703"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I4210125886","display_name":"Al-Azhar University","ror":"https://ror.org/03ewepe58","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210125886"]}],"countries":["EG","ID"],"is_corresponding":true,"raw_author_name":"Hazem Elkady","raw_affiliation_strings":["Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University","Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University","institution_ids":["https://openalex.org/I184834183","https://openalex.org/I4210125886"]},{"raw_affiliation_string":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt","institution_ids":["https://openalex.org/I184834183"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5020589815","https://openalex.org/A5048991764"],"corresponding_institution_ids":["https://openalex.org/I184834183","https://openalex.org/I4210125886"],"apc_list":{"value":1880,"currency":"GBP","value_usd":2306},"apc_paid":{"value":1880,"currency":"GBP","value_usd":2306},"fwci":4.3625,"has_fulltext":true,"cited_by_count":61,"citation_normalized_percentile":{"value":0.96728036,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"37","issue":"1","first_page":"2063","last_page":"2077"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzoxazole-derivatives","display_name":"benzoxazole derivatives","score":1.0},{"id":"https://openalex.org/keywords/vegfr-2-inhibitors","display_name":"VEGFR-2 inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/apoptosis-induction","display_name":"apoptosis induction","score":0.7829999923706055},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.9670000076293945},{"id":"https://openalex.org/keywords/hepg2-cells","display_name":"HepG2 cells","score":0.9729999899864197},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.996999979019165},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.8640000224113464},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9070000052452087},{"id":"https://openalex.org/keywords/bax-bcl-2-ratio","display_name":"Bax/Bcl-2 ratio","score":0.7440000176429749},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.6520000100135803},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.6700000166893005},{"id":"https://openalex.org/keywords/anticancer-drug-design","display_name":"anticancer drug design","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C2778047396","wikidata":"https://www.wikidata.org/wiki/Q761111","display_name":"Benzoxazole","level":2,"score":0.8985096216201782},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.636157751083374},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.5814107656478882},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.5629591941833496},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5583791732788086},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5553508996963501},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4984409809112549},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4712156355381012},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.46848997473716736},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.43712860345840454},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.4345608949661255},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.4304283559322357},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.4207039475440979},{"id":"https://openalex.org/C2777752112","wikidata":"https://www.wikidata.org/wiki/Q903238","display_name":"Lead compound","level":3,"score":0.41317906975746155},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4060256779193878},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3618202805519104},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30278414487838745},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.17253586649894714},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.07246047258377075},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.06644502282142639},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001583","descriptor_name":"Benzoxazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D040301","descriptor_name":"Vascular Endothelial Growth Factor Receptor-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/14756366.2022.2103552","doi":"https://doi.org/10.1080/14756366.2022.2103552","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14756366.2022.2103552","pdf_url":null,"source":{"id":"https://openalex.org/S192603849","display_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","issn_l":"1475-6366","issn":["1475-6366","1475-6374"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9327782","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9327782/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9327782/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Enzyme Inhib Med Chem","raw_type":"Text"},{"id":"pmid:35875937","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35875937","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of enzyme inhibition and medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:f180310e302d49f29cd0dbeea3e88d77","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/f180310e302d49f29cd0dbeea3e88d77","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 37, Iss 1, Pp 2063-2077 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1080/14756366.2022.2103552","doi":"https://doi.org/10.1080/14756366.2022.2103552","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14756366.2022.2103552","pdf_url":null,"source":{"id":"https://openalex.org/S192603849","display_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","issn_l":"1475-6366","issn":["1475-6366","1475-6374"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Enzyme Inhibition and Medicinal Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3549248427","display_name":null,"funder_award_id":"PNURSP2022R116","funder_id":"https://openalex.org/F4320322484","funder_display_name":"Princess Nourah Bint Abdulrahman University"}],"funders":[{"id":"https://openalex.org/F4320322484","display_name":"Princess Nourah Bint Abdulrahman University","ror":"https://ror.org/05b0cyh02"},{"id":"https://openalex.org/F4320330007","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4287218671.pdf","grobid_xml":"https://content.openalex.org/works/W4287218671.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1416958482","https://openalex.org/W1971318845","https://openalex.org/W1983790923","https://openalex.org/W1992591040","https://openalex.org/W1992905076","https://openalex.org/W2055265038","https://openalex.org/W2082746308","https://openalex.org/W2085663480","https://openalex.org/W2100374586","https://openalex.org/W2105649494","https://openalex.org/W2135732933","https://openalex.org/W2142616277","https://openalex.org/W2143926802","https://openalex.org/W2164030122","https://openalex.org/W2411726279","https://openalex.org/W2593436234","https://openalex.org/W2733738915","https://openalex.org/W2785579854","https://openalex.org/W2792389705","https://openalex.org/W2792416758","https://openalex.org/W2811066730","https://openalex.org/W2889072707","https://openalex.org/W2899260996","https://openalex.org/W2913078570","https://openalex.org/W2939027651","https://openalex.org/W2969802526","https://openalex.org/W2988361120","https://openalex.org/W3014033393","https://openalex.org/W3081465438","https://openalex.org/W3081848457","https://openalex.org/W3082495518","https://openalex.org/W3091632921","https://openalex.org/W3096002562","https://openalex.org/W3133533360","https://openalex.org/W3159182064","https://openalex.org/W3163986876","https://openalex.org/W3187698246","https://openalex.org/W3195108149","https://openalex.org/W3206811405","https://openalex.org/W3208102345","https://openalex.org/W4200193244","https://openalex.org/W4200291296","https://openalex.org/W4212872812","https://openalex.org/W4220934822","https://openalex.org/W4242372416","https://openalex.org/W4248107770","https://openalex.org/W4281789995","https://openalex.org/W4283257738","https://openalex.org/W6671024919"],"related_works":["https://openalex.org/W4200291296","https://openalex.org/W3159203841","https://openalex.org/W3163986876","https://openalex.org/W3133533360","https://openalex.org/W4292452138","https://openalex.org/W3215860977","https://openalex.org/W2769328077","https://openalex.org/W4205849281","https://openalex.org/W2979647576","https://openalex.org/W7166851125"],"abstract_inverted_index":{"In":[0],"this":[1],"study,":[2],"a":[3,113,124,145],"set":[4],"of":[5],"novel":[6],"benzoxazole":[7],"derivatives":[8],"were":[9,39],"designed,":[10],"synthesised,":[11],"and":[12,25,34,38,58,63,95,120,123],"biologically":[13],"evaluated":[14],"as":[15],"potential":[16],"VEGFR-2":[17,44,70],"inhibitors.":[18],"Five":[19],"compounds":[20],"(12d,":[21],"12f,":[22],"12i,":[23],"12l,":[24],"13a)":[26],"displayed":[27],"high":[28],"growth":[29,90],"inhibitory":[30,45,71],"activities":[31],"against":[32,61],"HepG2":[33,62,88,105],"MCF-7":[35],"cell":[36,89],"lines":[37],"further":[40,78],"investigated":[41],"for":[42],"their":[43],"activities.":[46],"The":[47],"most":[48,68],"potent":[49],"anti-proliferative":[50],"member":[51],"12":[52],"l":[53],"(IC50":[54,73],"=":[55,74],"10.50":[56],"\u03bcM":[57,60],"15.21":[59],"MCF-7,":[64],"respectively)":[65],"had":[66],"the":[67,87,93,140],"promising":[69],"activity":[72],"97.38":[75],"nM).":[76],"A":[77],"biological":[79],"evaluation":[80],"revealed":[81],"that":[82,135],"compound":[83,99,110],"12l":[84,100,111,136],"could":[85,101],"arrest":[86],"mainly":[91],"at":[92],"Pre-G1":[94],"G1":[96],"phases.":[97],"Furthermore,":[98],"induce":[102],"apoptosis":[103],"in":[104,116,127,144],"cells":[106],"by":[107],"35.13%.":[108],"likely,":[109],"exhibited":[112,137],"significant":[114,125],"elevation":[115],"caspase-3":[117],"level":[118,129],"(2.98-fold)":[119],"BAX":[121],"(3.40-fold),":[122],"reduction":[126],"Bcl-2":[128],"(2.12-fold).":[130],"Finally,":[131],"docking":[132],"studies":[133],"indicated":[134],"interactions":[138],"with":[139],"key":[141],"amino":[142],"acids":[143],"similar":[146],"way":[147],"to":[148],"sorafenib.":[149]},"counts_by_year":[{"year":2026,"cited_by_count":14},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":17},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":4}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2022-07-25T00:00:00"}